Table 1.
Clinical characteristics of patients undergoing hepatic resection (HR) or hepatic enucleation (HE) for giant hepatic haemangioma
| Clinical characteristics | HE group (n = 386) | HR group (n = 344) | P-value |
|---|---|---|---|
| Gender, male, n (%) | 224 (58.0%) | 205 (59.6%) | 0.764 |
| Age, years, median (range) | 45 (20–70) | 46 (21–68) | 0.455 |
| ASA status (I/II/III), n | 267/111/8 | 245/92/7 | 0.327 |
| Surgical indications, n (%) | |||
| Symptomatic | 222 (57.5%) | 197 (57.3%) | 0.234 |
| Progressive increase in size | 89 (23.1%) | 80 (23.3%) | 0.542 |
| Haemangioma related complications | 42 (10.9%) | 37 (10.8%) | 0.324 |
| Uncertain diagnosis | 24 (6.2%) | 22 (6.4%) | 0.265 |
| Other | 9 (2.3%) | 8 (2.3%) | 0.321 |
| Tumour location (segment), n | |||
| I | 3 | 5 | 0.132 |
| II, III | 44 | 39 | 0.228 |
| IV | 98 | 88 | 0.176 |
| V, VI | 166 | 147 | 0.253 |
| VII, VIII | 75 | 65 | 0.154 |
| Largest tumour size, cm, median (range) | 9.8 (1.5–5.7) | 10.6 (1.8–4.4) | 0.752 |
| Solitary haemangioma, n (%) | 304 (78.8%) | 276 (80.2%) | 0.541 |
ASA, American Society of Anesthesiologists.